Elekta Medical Linear Accelerator
Device Linac Solutions (Linac)
PDI 05060191071550
General payments
$8,251,070
Research payments
$451,290
Through program year 2025, $8,251,070 in general payments and $451,290 in research payments were reported against Elekta Medical Linear Accelerator (Linac Solutions (Linac)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $155,052 | 230 |
| 2025 | Research | $184,540 | 5 |
| 2024 | General | $22,332 | 306 |
| 2023 | General | $225,383 | 555 |
| 2023 | Research | $266,750 | 2 |
| 2022 | General | $134,256 | 215 |
| 2021 | General | $7,714,047 | 181 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 33 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,487 general · 7 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.